Tuesday, November 10, 2020 12:38:42 PM
Great earnings release recntly. ALT established a Sponsored Research Agreement with Dr.James Brien, Asst. Prof at Molecular Microbiology and Immunology at SLU. Expertise studying in pathogenicity of viral infections and part of a network of clinical sites evaluating OWS vaccines. Looking to hold long.
Recent ALT News
- Altimmune Announces Closing of $225 Million Oversubscribed Public Offering of Securities • GlobeNewswire Inc. • 04/27/2026 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/24/2026 08:05:27 PM
- Altimmune Announces Pricing of $225 Million Oversubscribed Public Offering of Securities • GlobeNewswire Inc. • 04/23/2026 03:25:00 AM
- Form S-3MEF - Registration adding securities to prior Form S-3 registration [Rule 462(b)] • Edgar (US Regulatory) • 04/23/2026 01:15:33 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 04/22/2026 09:24:39 PM
- Altimmune Announces Proposed Underwritten Public Offering of Securities • GlobeNewswire Inc. • 04/22/2026 08:19:41 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/16/2026 09:07:34 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/06/2026 08:05:16 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/01/2026 08:05:14 PM
- Anti-Aging Protein Research Takes a Step Forward with Cell Cloning • PR Newswire (US) • 03/24/2026 03:05:00 PM
- Anti-Aging Protein Research Takes a Step Forward with Cell Cloning • PR Newswire (Canada) • 03/24/2026 03:05:00 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 03/17/2026 11:13:05 AM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 03/17/2026 11:05:15 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/09/2026 11:00:05 AM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 03/06/2026 01:01:41 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/06/2026 12:56:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/05/2026 12:08:14 PM
- Altimmune Announces Fourth Quarter and Full-year 2025 Financial Results and Business Updates • GlobeNewswire Inc. • 03/05/2026 12:00:00 PM
- Altimmune to Participate in Upcoming Investor Conferences • GlobeNewswire Inc. • 03/02/2026 12:30:00 PM
- Altimmune to Report Fourth Quarter and Full Year 2025 Financial Results and Provide Business Update on March 5, 2026 • GlobeNewswire Inc. • 02/26/2026 12:30:00 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 02/06/2026 09:07:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/03/2026 09:15:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/03/2026 09:05:32 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/02/2026 09:15:29 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/02/2026 09:10:06 PM
